Literature DB >> 16141640

Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses.

Sibel Silici1, Nedret A Koç, Demet Ayangil, Soner Cankaya.   

Abstract

Yeasts isolated from patients with superficial mycoses were tested against propolis samples collected from different regions and honeybee races. The minimum inhibitory concentration (MIC) values obtained using the agar dilution methods were compared to the diameters of growth inhibition zones by using the disk diffusion method. The results showed that Candida albicans, C. glabrata, Trichosporon spp., and Rhodotorula sp. were susceptible to low concentrations of propolis, the latter showing a higher susceptibility. Relative to the other propolis tested, the propolis sample collected by Apis mellifera caucasica possessed the highest antifungal activity against all of the superficial mycoses. In contrast, the propolis samples collected by A.m. carnica and A.m. anatolica were the least active samples. Also, the propolis sample from the Adana region is more active than samples from other regions. An increase of MIC values was accompanied by a decrease of growth inhibition zone diameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141640     DOI: 10.1254/jphs.fpe05002x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  17 in total

1.  Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.

Authors:  Nuri Kiraz; Ilknur Dag; Mustafa Yamac; Abdurrahman Kiremitci; Nilgun Kasifoglu; Yasemin Oz
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

2.  Biotransformation strategy to reduce allergens in propolis.

Authors:  Claudio Gardana; Andrea Barbieri; Paolo Simonetti; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-04-20       Impact factor: 4.792

3.  Antifungal Activity of Propolis Against Yeasts Isolated From Blood Culture: In Vitro Evaluation.

Authors:  Fatma Mutlu Sariguzel; Elife Berk; Ayes Nedret Koc; Hafize Sav; Gonca Demir
Journal:  J Clin Lab Anal       Date:  2016-01-20       Impact factor: 2.352

4.  Antibacterial and mechanical properties of propolis added to glass ionomer cement.

Authors:  Erdem Hatunoğlu; Fırat Oztürk; Tuğça Bilenler; Sertaç Aksakallı; Neslihan Simşek
Journal:  Angle Orthod       Date:  2013-08-14       Impact factor: 2.079

Review 5.  An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.

Authors:  Sanowar Hossain; Muhammad Yousaf; Yang Liu; Dennis Chang; Xian Zhou
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

6.  Antifungal chemical compounds identified using a C. elegans pathogenicity assay.

Authors:  Julia Breger; Beth Burgwyn Fuchs; George Aperis; Terence I Moy; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

7.  Evaluating the In-vitro Antibacterial Effect of Iranian Propolis on Oral Microorganisms.

Authors:  Tahereh Sadat Jafarzadeh Kashi; Ruha Kasra Kermanshahi; Mohammad Erfan; Elahe Vahid Dastjerdi; Yashar Rezaei; Fahimeh Sadat Tabatabaei
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

8.  Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions.

Authors:  Julio Beltrame Daleprane; Dulcinéia Saes Abdalla
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-08       Impact factor: 2.629

9.  Brazilian propolis: a natural product that improved the fungicidal activity by blood phagocytes.

Authors:  Muryllo Mendes Possamai; Adenilda Cristina Honorio-França; Ana Paula Barcelos Reinaque; Eduardo Luzia França; Paula Cristina de Souza Souto
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

10.  Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro.

Authors:  Isabel Valença; Filipa Morais-Santos; Vera Miranda-Gonçalves; Ana Margarida Ferreira; Cristina Almeida-Aguiar; Fátima Baltazar
Journal:  BMC Complement Altern Med       Date:  2013-07-19       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.